Addressing diabetic foot ulcer trajectories through social genomics research

Not Applicable

Recruiting

• Conditions: Diabetes Mellitus; Diabetic Foot Disease; Metabolic and Endocrine - Diabetes; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system; Neurological - Other neurological disorders

• Registration Number: ACTRN12621000299808
• Lead Sponsor: South Western Sydney Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-18
• Last Update Posted: 7 September 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

All participants:
Type 1 or 2 Diabetes Mellitus
Aged over 18 years
Consent to participate

Cohort 1 inclusion criteria:
Diabetic Foot ulcer below the malleolus

Cohort 2 inclusion criteria
No history of diabetic foot disease

Exclusion Criteria

- Malignant ulcers
- Ulcers associated with chemotherapy
- Venous Ulceration
- Thermal injuries
- Uncontrolled anticoagulation therapy (warfarin, clopidogrel, and INR > 2.0)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of diabetic foot ulcers healed - defined as 100% epithelialisation with no exudate through physical examination by treating podiatrist. [At every appointment attended (typically 1-2 weeks) for 2 years, or until 100% epithelialisation occurs. ]